Skip to main content
The Oncologist logoLink to The Oncologist
. 2015 May;20(5):570. doi: 10.1634/theoncologist.2014-0037erratum

Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors

Francesco Panzuto, Maria Rinzivillo, Nicola Fazio, Filippo de Braud, Gabriele Luppi, Maria Chiara Zatelli, Francesca Lugli, Paola Tomassetti, Ferdinando Riccardi, Carmen Nuzzo, Maria Pia Brizzi, Antongiulio Faggiano, Alberto Zaniboni, Elisabetta Nobili, Davide Pastorelli, Stefano Cascinu, Marco Merlano, Silvana Chiara, Lorenzo Antonuzzo, Chiara Funaioli, Francesca Spada, Sara Pusceddu, Annalisa Fontana, Maria Rosaria Ambrosio, Alessandra Cassano, Davide Campana, Giacomo Cartenì, Marialuisa Appetecchia, Alfredo Berruti, Annamaria Colao, Massimo Falconi, Gianfranco Delle Fave
PMCID: PMC4425385  PMID: 25956900

The Oncologist 2014;19:966-974; first published on August 12, 2014; doi:10.1634/theoncologist.2014-0037

The affiliations for authors Marialuisa Appetecchia and Elisabetta Nobili were identified incorrectly in the original publication. The error is corrected in the online publication. The correct affiliations are as follows:

Marialuisa Appetecchia: Endocrinology Unit, Regina Elena National Cancer Institute, IRCCS, Rome, Italy

Elisabetta Nobili: Medical Oncology, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy


Articles from The Oncologist are provided here courtesy of Oxford University Press

RESOURCES